CGB 7.14% 0.8¢ cann global limited

Future predctions, page-38

  1. 1,156 Posts.
    lightbulb Created with Sketch. 203
    @Bilson Hi Matt,
    Medican's facility fit out has already begun. I'm not sure how the company not purchasing Medican at this point will have an effect on it but I highly doubt it will take years to compleat considering it should be finished in the next few months.

    As for statements about ODC license you are correct, Biohealth dosen't have them. On the flip side Medican dosen't any licenses to manufacture pharmaceuticals etc.
    I don't know how CGB intends to get its leaf. I think your questions about it are fair but lets think about it logically. Would the company really say they are going to push forward massive short term revenue (this year) if they didn't have a supply? I know people such as yourself have a large distrust for the BOD but I think to say they would do that is a bit far even from you.

    And Neil has covered that Medican will still be producing for CGB and allowing them to use the licenses.
    @Neil1959 perhaps you could shed some light on how Management will get the products to manufacture our pharmaceuticals?
    Last edited by Pan head: 14/02/19
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.